MedTrace Logo

BIOLUX P-III All-Comers Passeo-18 Lux Registry

NCT02276313 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 880

Last updated 2022-08-15

No results posted yet for this study

Summary

BIOLUX P-III is a prospective, international, multi-centre, postmarket all-comers registry to collect clinical performance data on the Passeo-18 Lux paclitaxel releasing balloon catheter in the treatment of atherosclerotic disease of the infrainguinal arteries.

Conditions

Interventions

DEVICE

Passeo-18 Lux

Endovascular Therapy

Sponsors & Collaborators

  • Biotronik AG

    lead INDUSTRY

Principal Investigators

  • Gunnar Tepe, MD · RoMed Klinikum Rosenheim

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2018-04-30
Completion
2022-01-31

Countries

  • Australia
  • Austria
  • Belgium
  • Denmark
  • Finland
  • France
  • Germany
  • Italy
  • Latvia
  • Malaysia
  • Netherlands
  • Portugal
  • Singapore
  • Slovakia
  • Spain
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02276313 on ClinicalTrials.gov